AI-generated invoices with CMS-216 line-item categorization performed at the transaction level. Eliminates the retroactive cost-report reconstruction OPO finance teams run during audit preparation.
MeiraPay generates invoices and categorizes every line item against the CMS-216 cost report at the moment of issue. Finance teams stop reconstructing months of transactions in audit-prep windows that should never have required reconstruction in the first place.
The CMS-216 cost report classifies organ acquisition expenses across roughly 40 line categories. Today, most OPO finance teams perform that categorization retroactively, in concentrated audit-prep cycles, by reviewing months of receipts, invoices, and labor logs. The work is slow, error-prone, and unverifiable downstream. As more vendors transact through MeiraPay, the platform consolidates the field's procurement flow into a single auditable system: categorization, payment, and operational signal aggregated across buyer and seller.
Categorize at the transaction. MeiraPay invoices are categorized as they're generated, with the categorization itself documented and auditable per-transaction. The cost report is a continuous read against the same underlying data, not a quarterly reconstruction event.
Built on the same compliance-native engineering foundation as MeiraWorks and Atlas. Audit-traceable end-to-end. FY 2027 IPPS final-rule changes accommodated in the categorization schema.
Every invoice carries its categorization metadata. The cost report is a query against the transaction record, not a retroactive reclassification cycle.
Each categorization decision is logged with its source documents, AI-suggested categorization, and human acceptance. Auditors see the full chain.
Categorization schema tracks the FY 2027 IPPS final-rule changes for organ acquisition cost reporting. Finance teams don't reset their classification workflows when the rule lands.
Vendors selling into U.S. organ donation and transplant currently invoice into 55 OPOs and 200+ transplant programs separately. MeiraPay consolidates that surface: one invoicing format, one payment rail, audit-traceable categorization metadata included.
MeiraPay is in evaluation with select OPO finance teams, transplant-center AR teams, and vendors. Reach out by track.
If your team prepares the CMS-216 organ acquisition cost report and is interested in evaluating MeiraPay's categorization-at-issue workflow, let's talk.
Reach out →Transplant-center finance teams reconciling acquisition charges from multiple OPOs can use MeiraPay's categorization metadata to validate against their internal AR.
Reach out →If your company sells products or services into OPOs or transplant centers and currently maintains separate invoicing relationships with each buyer, MeiraPay consolidates that into one rail.
Reach out about vendor onboarding →